Maintenance Notice (8:45 AM - 1:00 PM February 22, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | New tool "TCI SpectraViewer" | [Product Highlights] Chemiluminescent Reagents for... | Product Document Searching Made Easy by 2D Code!
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 1772-03-8 | Product Number: G0007
D-(+)-Galactosamine Hydrochloride
×
![]()
×
Purity: >98.0%(HPLC)(N)
Synonyms:
- Chondrosamine Hydrochloride
Product Documents:
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 1G |
₹6,300.00
|
2 | 3 |
|
| 5G |
₹18,300.00
|
8 | ≥40 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | G0007 |
| Purity / Analysis Method | >98.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | C__6H__1__3NO__5·HCl = 215.63 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 1772-03-8 |
| Reaxys Registry Number | 4155115 |
| PubChem Substance ID | 87570235 |
| Merck Index (14) | 4334 |
| MDL Number | MFCD00135830 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC)(CAD) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 98.0 % |
| Specific rotation [a]20/D | +94.0 to +98.0 deg(C=1, H2O) |
Properties (reference)
| Melting Point | 176 °C |
| Specific Rotation | 96° (C=1,H2O) |
GHS
Related Laws:
| RTECS# | LW5500000 |
Transport Information:
Application
Reagent for hepatic failure
References
- Experimental hepatitis induced by D-galactosamine
- Proline protects liver from D-galactosamine hepatitis by activating the IL-6/STAT3 survival signaling pathway
- Metabolic studies in experimental liver disease resulting from D(+)-galactosamine administration
- Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death
- K. Decker, D. Keppler, Rev. Physiol. Biochem. Pharmacol. 1974, 71, 77.
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.